APA (7th ed.) Citation

Barratt J, Kristensen J, Pedersen C, & Jerling M. (2024). Insights on Nefecon®, a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy. Dove Medical Press.

Chicago Style (17th ed.) Citation

Barratt J, Kristensen J, Pedersen C, and Jerling M. Insights on Nefecon®, a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy. Dove Medical Press, 2024.

MLA (9th ed.) Citation

Barratt J, et al. Insights on Nefecon®, a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy. Dove Medical Press, 2024.